# Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease

> **Open Intelligence Dossier** · First detected: 2026-09-23 14:00 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include The Clinical Trial Vanguard, Investing.com India, Endpoints News and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| The Clinical Trial Vanguard | Roche’s Sefaxersen Meets Primary Endpoint in Phase 3 IgAN Study | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxQc0d6T2ItampoekNBOHk5MWFXems1Y3dNaGtLYXRrUzNpSDBtVW5VZlk2NEJpNkV5NXJLdjZ6a0VmWUhPMjhJeElhYzZKNkZFTGQyNmhWUE13eTVuaUVJXzUtNzFrMlptUDcyb2tHRGpkRnBldWVscmV6a0djNE9UaWhpaEZKZ21DdUxPeWhWVy14NmVNMEhKZ0ZmRk1Gd3V3elBnTWdVUThxUQ?oc=5) |
| Investing.com India | Form 8K IONIS PHARMACEUTICALS For: 23 September By Investing.com | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxQaXl1MWRwNndSVlFHVU0yRVRTZFRWbUo5V2ZBb3VxdnF5WG1aaTFzZjFOUFNmQVEtWlY2UURoWng5dWdFck5iY011d0xDTHJEMWxKLXhmdG16MHcwVVJxN3FRNW5UOHFvS2c2UEJCQWhPRGxtS3pnaG5mbGVkbHdJSGdLampuU1l5OW5LMjdwdzY3WExzdzRZb2dCUWZaRk80Z0UybEg5a1FvQ1U?oc=5) |
| Endpoints News | Roche kidney drug’s Phase 3 win sets up path to accelerated approval | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxNRWdkSjNXRkhxbXN6bmJMQUZtOVd6bEdWUWprLUNMb3VhYzBXb1JfaXUzbGlCcjEwbXliQzdOajhpRGZJZDF1Y1QtVXJIc2dRUVIyQlYwbjdmaXJjQ2paZ0RSU3BvWkdkOEpiQ3hkUXA4MWl1MlRhUjduRlh4a0FLR1lfU01QbE5HaHR0U3FZVGg0MHZnb0E?oc=5) |
| Fierce Biotech | Roche’s phase 3 win tees up fight with Novartis for blockbuster kidney disease market | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxQUzExc3FTRW02c1Zqa3RyR1VMNUJkQVBsM1VqODJZVVZpdWZDYWFCLWo1N1JWYlUwN3RtRm9YUllfT2EyOGNCQ29MeE1KTE5sWE9mTF8wN1BHYnV6OXlQZ1ZNdFgwMzdQR01QMWg3WVpzWWNxU1BBaTQ0NXh6SEV2NjNSNlNPSW5SNE9XNlZzbWc4enZRNFUzRnZGdThVUXNOVTVqRGVkanNuVmhJY2Mw?oc=5) |
| WSJ | Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease | [Source Link](https://news.google.com/rss/articles/CBMiugFBVV95cUxOTHdENDgzNGg3MDh4UFZPd0d3TkF2QlpMa0lvOWNGSU9uZlFfSkd2QTZUNWRONVhudC1DZng2TUp2eWpYSXhHNTBxODlTODNaTWVlNmdzSUo3X2JDTi1SMVhkcjlPcl9vRGlUZ011MTRadzVLMHBuVEZrUzB0Qm1UajZicVNQUEFBbEhPVnVjN3M2MTM5ZUFNRmpuZjhOeXRCRmRTMWMyU2M3WTgyRVFRWDJfRzdTdjJZeXc?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-09-23/roche-drug-candidate-hits-target-in-late-stage-study-for-autoimmune-disease*